Diskussionsleitung: A. Abdin (Homburg/Saar), R. Bosch (Ludwigsburg)
| (P1201) | Single center experience of baroreflex activation therapy in heart failure with reduced ejection fraction. | |
| C. Blanco, E. B. Winzer, N. Mangner, K. M. Sveric, S. Grimm, M. Flechsig, T. Madej, M. Knaut, A. Linke (Dresden) | ||
| (P1202) | Erste klinische Daten zur Effektivität der Kardialen Kontraktilitätsmodulation bei NYHA-II-Patienten – Ergebnisse der MAINTAINED Observational Study | |
| C. Fastner, G. Yücel, B. Rudic, G. Schmiel, M. Toepel, V. Liebe, M. Kruska, S. Hetjens, D. Dürschmied, I. Akin, J. Kuschyk (Mannheim) | ||
| (P1203) | Impact of atrial flow regulator implantation on survival in patients with heart failure with reduced and preserved ejection fraction: A post-hoc analysis of the AFR-Prelieve Trial | |
| L. Lauder, M. W. Bergmann, C. Paitazoglou, Ö. Ramazan, R. Pfister, J. Bartunek, A. Lauten, H. Sievert, S. D. Anker, F. Mahfoud, für die Studiengruppe: AFR-PRELIEVE (Homburg/Saar, Hamburg, Lübeck, Köln, Erfurt, Frankfurt am Main, Berlin; Fatih, TR; Aalst, BE) | ||
| (P1204) | Relevance of heart rate recovery for individuals with heart failure – Results from the MyoVasc study | |
| D. Velmeden, J. Söhne, A. Schuch, S. Zeid, A. Schulz, S.-O. Tröbs, F. Müller, M. Heidorn, G. Buch, W. Dinh, K. Lackner, T. Gori, T. Münzel, P. S. Wild, J. Prochaska, für die Studiengruppe: DZHK (Mainz, Wuppertal) | ||
| (P1205) | Heart rate variability as determinant of cardiovascular status and predictor of mortality in individuals with heart failure - Results from the MyoVasc study | |
| S. Zeid, G. Buch, D. Velmeden, J. Söhne, A. Schulz, A. Schuch, S.-O. Tröbs, M. Heidorn, F. Müller, K. Coboeken, K. Lackner, T. Gori, T. Münzel, J. Prochaska, P. S. Wild (Mainz, Wuppertal) | ||
| (P1206) | Clinical implications and risk factors for QRS progression in heart failure patients | |
| M. Berger, N. Kumowski, S. Straw, M. Verket, N. Marx, K. Witte, K. Schütt (Aachen; Leeds, UK) | ||
| (P1207) | Iron Deficiency in Heart Failure Patients with Implantable Cardioverter-Defibrillators (ICD) and Cardiac Resynchronization Therapy Devices (CRT): Prevalence and Association with Symptom Severity | |
| L. K. Krieglstein, S. Achenbach, M. B. Arnold, C. Merkel, L. Anneken (Erlangen) | ||
| (P1208) | Prognostic impact of asymptomatic lead-associated intracardiac thrombi after device implantation in an all-comers patient cohort | |
| I. I. Müller, L.-K. Isser, P. Seizer, J. Schreieck, M. Gawaz, K. A. L. Müller, K.-P. Kreißelmeier (Tübingen, Aalen) |
